Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2008
11/20/2008US20080287482 Production of Polyketides and Other Natural Products
11/20/2008US20080287471 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
11/20/2008US20080287470 Presentation of an Antiviral Pharmaceutical Composition
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287449 Aza-tripeptide hepatitis c serine protease inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287443 Treatment of Subgingival Pocket Infections
11/20/2008US20080287442 Organic Compounds
11/20/2008US20080287440 Novel Antifungal Triazole Derivatives
11/20/2008US20080287434 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/20/2008US20080287411 Optically active dihydropyridine derivative
11/20/2008US20080287401 Methods for Synthesizing and Purifying Aminoalkyl Tetracycline Compounds
11/20/2008US20080287396 Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections
11/20/2008US20080287394 hydroxy-substituted pyrazinopyrrolopyridazine dione compounds; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(2-fluorobenzyl)-10-hydroxy-4,8-dimethyl-7,8-dihydropyrazino[1',2':1,5]-pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-dione
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080287389 Nucleoside analogs in combination therapy of herpes simplex infections
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287376 Ketolide Derivatives as Antibacterial Agents
11/20/2008US20080287361 Compositions and methods of using CRMP-1 and its fragments for treating cancer
11/20/2008US20080287357 Conjugate Comprising P21 Protein for the Treatment of Cancer
11/20/2008US20080287347 Novel Lipopeptides as Antibacterial Agents
11/20/2008US20080287346 Bioactive peptides
11/20/2008US20080287345 Polymyxin derivatives and uses thereof
11/20/2008US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof
11/20/2008US20080286755 Immunoglobin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
11/20/2008US20080286406 Lactic Acid Bacteria
11/20/2008US20080286356 Pharmaceutical compositions containing terbinafin and use thereof
11/20/2008US20080286353 Cationic liposomes containing immune response generating moieties
11/20/2008US20080286350 Formulation of Multivalent Antibody Constructs and Use of Same for Cancer Therapy
11/20/2008US20080286344 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients
11/20/2008US20080286343 Solid form
11/20/2008US20080286316 Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods
11/20/2008US20080286309 Portion of SpaA protein is deleted for protection from Erysipelothrix rhusiopathiae infection; genetic engineering; Porcine erysipelas; high purity
11/20/2008US20080286308 Respiratory disease in cattle; immunostimulants; bioassay
11/20/2008US20080286306 Plasmid DNA or viral vector vaccine including components from different clades of Env and Gag-Pol-Nef from a single clade; multiclade HIV envelope immunogen
11/20/2008US20080286303 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media
11/20/2008US20080286302 Two live mutant viruses of the same family containing a mutation in the viral genome at the same genomic site so the mutant viruses cannot recombine with each other to eliminate the mutations; Bovine viral diarrhea virus ; veterinary medicine
11/20/2008US20080286300 Improved quality control for conjugate vaccines; faster and more reproducible separation; analysis of mixed meningococcal saccharides from multiple serogroups even though they share monosaccharide units; meningoccocus; analyses sialic acid, glucose and galactose content
11/20/2008US20080286299 Film-forming resins as a carrier for topical application of pharmacologically active agents
11/20/2008US20080286296 Cyclic-Dinucleotides and Its Conjugates as Adjuvants and Their Uses in Pharmaceutical Compositions
11/20/2008US20080286291 Betulinol Derivatives as Anti-Hiv Agents
11/20/2008US20080286290 Anti-Cd14 Antibody Fusion Protein
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
11/20/2008US20080286275 Antigen Binding Proteins Directed Against Scavenger Receptor B1 that Inhibit Hcv Replication
11/20/2008US20080286274 Vector for Efficient Selection and/or Maturation of an Antibody and Uses Thereof
11/20/2008US20080286247 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
11/20/2008US20080286238 Recombinant Adenovirus Expressing A Gene Encoding Streptolysin O Proetin and Anti-Cancer Composition Comprising Same
11/20/2008US20080286236 Inhibition of yersinia pestis
11/20/2008US20080286233 Piperizinyl macrocyclic hepatitis c serine protease inhibitors
11/20/2008US20080286230 Compounds and pharmaceutical compositions for the treatment of viral infections
11/20/2008US20080286223 Compositions Having a High Antiviral and Antibacterial Efficacy
11/20/2008US20080286213 Comprising morusin, Cortex Mori (White Mulberry root-bark), for use in manufacturing antibacterial medicaments or oral care products; treatment of caries and periodontal disease
11/20/2008US20080286212 Antimicrobial Formulations and Methods of Using the Same
11/20/2008US20080286210 Novel antimicrobial peptides
11/20/2008DE102005059420B4 Verwendung einer Hypromellose enthaltende zu einer Buccaltablette gepressten Haftpaste zur Behandlung lokaler Erkrankungen der Mundschleimhaut Using a Hypromellose containing compressed to a buccal adhesive paste for treatment of local diseases of the oral mucosa
11/20/2008CA2687410A1 Uses of north american ginseng fractions for treating leukemia
11/20/2008CA2687115A1 Treatment and prevention of influenza
11/20/2008CA2686997A1 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008CA2686994A1 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008CA2686766A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
11/20/2008CA2686546A1 Novel peptide inhibitors of hepatitis c virus replication
11/20/2008CA2686489A1 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008CA2685888A1 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/20/2008CA2685520A1 Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
11/20/2008CA2682700A1 Composition containing hcmv particles
11/20/2008CA2670014A1 Production of anti-microbial peptides
11/20/2008CA2667297A1 Oligoribonucleotides and uses thereof
11/19/2008EP1992634A1 Oligonucleotide n3'- p5' thiophosphoramidates: their synthesis and use
11/19/2008EP1992629A1 Preparation of levofloxacin and forms thereof
11/19/2008EP1992628A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
11/19/2008EP1992359A1 Neurotropic virus transport
11/19/2008EP1992358A1 Aids vaccine based on replicative vaccinia virus vector
11/19/2008EP1992335A1 Spray drying methods and compositions thereof
11/19/2008EP1991533A1 Chemical compounds
11/19/2008EP1991529A1 Substituted arylsulfonamides as antiviral agents
11/19/2008EP1991264A2 Compositions that include hemagglutinin, methods of making and methods of use thereof
11/19/2008EP1991229A2 Co-crystals and pharmaceutical compositions comprising the same
11/19/2008EP1991216A1 Means and methods for influencing interactions between dc-sign and dc-sign ligands
11/19/2008EP1991213A2 Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa)
11/19/2008EP1933856A4 Method for treatment or prevention of conditions caused by gram-positive bacteria
11/19/2008EP1613288B1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1428870B1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation
11/19/2008EP1320357B1 Topical polymeric antimicrobial emulsion
11/19/2008EP1284741B1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008EP1123711B1 Attenuated toxins as adjuvants
11/19/2008EP0969844B1 Administration of an injectable antibiotic in the ear of an animal
11/19/2008EP0925073B1 Staphylococcus aureus antigen
11/19/2008EP0888120B1 Immunogenic hla binding peptide and its uses to treat hiv infection
11/19/2008CN101309932A Novel mucin glycoprotein and use thereof
11/19/2008CN101309931A Vaccines comprising truncated HBC core protein plus saponin-based adjuvants
11/19/2008CN101309911A Hiv-1 protease inhibitors, and methods of making and using them
11/19/2008CN101309701A Vaccines and methods to treat canine influenza
11/19/2008CN101309700A Therapeutic use of outer shigella protein f (ospf)
11/19/2008CN101309696A Harmful bacterium control agent containing bacillus thuringiensis
11/19/2008CN101309693A Use of amine-borane compounds as anti-microbial agents
11/19/2008CN101309677A Cleaner for precaution against of cow's hoof, manufacturing method thereof, and using method thereof
1 ... 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 ... 1798